Mithra Pharmaceuticals SA. Stock Analysis MITRA.BR

Mithra Pharmaceuticals SA is a biotechnology company, which engages in the business of transforming women's health by offering new choices through innovation with a particular focus on contraception and menopause. The company is headquartered in Flemalle, Liege. The firm is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The firm provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a solution for oral contraception, PeriNesta, the oral treatment targeting perimenopause and Donesta, a hormone therapy. The firm also develops and manufactures therapeutics in the areas of contraception, menopause and hormone-dependent cancers. The company offers partners a spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. The firm operates in more than 100 countries around the world and is headquartered in Liege, Belgium.